基因工程抗体 Prof Sir Gregory Winter CBE FRS 单克隆抗体 The rise of antibody-based therapeutics further illustrates the substantial change in the paradigms of pharmaceutical development,by utilizing the body's own capabilities as a source for a drug 抗血清 rather than the chemists reagents vessel. Source:Nature Biotechnology 15 抗血清 单克隆抗体 基因工程抗体 The rise of antibody-based therapeutics further illustrates the substantial change in the paradigms of pharmaceutical development, by utilizing the body's own capabilities as a source for a drug rather than the chemists reagents vessel. Source: Nature Biotechnology Prof Sir Gregory Winter CBE FRS 15